Authors: Streetman, DS Kashuba, ADM Bertino, JS Kulawy, R Rocci, ML Nafziger, AN

Citation: Ds. Streetman et al., Use of midazolam urinary metabolic ratios for cytochrome P450 3A (CYP3A) phenotyping, PHARMACOGEN, 11(4), 2001, pp. 349-355

Authors: Streetman, DS Nafziger, AN Destache, CJ Bertino, JS

Citation: Ds. Streetman et al., Individualized pharmacokinetic monitoring results in less aminoglycoside-associated nephrotoxicity and fewer associated costs, PHARMACOTHE, 21(4), 2001, pp. 443-451

Authors: Streetman, DS Bertino, JS Nafziger, AN

Citation: Ds. Streetman et al., Phenotyping of drug-metabolizing enzymes in adults: a review of in-vivo cytochrome P450 phenotyping probes, PHARMACOGEN, 10(3), 2000, pp. 187-216

Authors: Streetman, DS Bleakley, JF Kim, JS Nafziger, AN Leeder, JS Gaedigk, A Gotschall, R Kearns, GL Bertino, JS

Citation: Ds. Streetman et al., Combined phenotypic assessment of CYP1A2, CYP2C19, CYP2D6, CYP3A, N-acetyltransferase-2, and xanthine oxidase with the "Cooperstown cocktail", CLIN PHARM, 68(4), 2000, pp. 375-383

Authors: Streetman, DS Ellis, RE Nafziger, AN Leeder, JS Gaedigk, A Gotschall, R Kearns, GL Bertino, JS

Citation: Ds. Streetman et al., Dose dependency of dextromethorphan for cytochrome P450 2D6 (CYP2D6) phenotyping, CLIN PHARM, 66(5), 1999, pp. 535-541